25 related articles for article (PubMed ID: 8249054)
1. Fluorescence-Based Assays for Measuring Doxorubicin in Biological Systems.
Kauffman MK; Kauffman ME; Zhu H; Jia Z; Li YR
React Oxyg Species (Apex); 2016; 2(6):432-439. PubMed ID: 29707647
[TBL] [Abstract][Full Text] [Related]
2. Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring.
Siebel C; Lanvers-Kaminsky C; Würthwein G; Hempel G; Boos J
Sci Rep; 2020 Oct; 10(1):18562. PubMed ID: 33122763
[TBL] [Abstract][Full Text] [Related]
3. Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia.
Fetterly GJ; Aras U; Lal D; Murphy M; Meholick PD; Wang ES
AAPS J; 2013 Jul; 15(3):662-73. PubMed ID: 23550025
[TBL] [Abstract][Full Text] [Related]
4. Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.
Voon PJ; Yap HL; Ma CY; Lu F; Wong AL; Sapari NS; Soong R; Soh TI; Goh BC; Lee HS; Lee SC
Br J Clin Pharmacol; 2013 Jun; 75(6):1497-505. PubMed ID: 23116553
[TBL] [Abstract][Full Text] [Related]
5. An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin.
Hirte H; Stewart D; Goel R; Chouinard E; Huan S; Stafford S; Waterfield B; Matthews S; Lathia C; Schwartz B; Agarwal V; Humphrey R; Seymour AL
Invest New Drugs; 2005 Oct; 23(5):437-43. PubMed ID: 16133795
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.
Arnold RD; Slack JE; Straubinger RM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):141-52. PubMed ID: 15261807
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).
Greenberg PL; Lee SJ; Advani R; Tallman MS; Sikic BI; Letendre L; Dugan K; Lum B; Chin DL; Dewald G; Paietta E; Bennett JM; Rowe JM
J Clin Oncol; 2004 Mar; 22(6):1078-86. PubMed ID: 15020609
[TBL] [Abstract][Full Text] [Related]
8. Effect of coenzyme Q10 on the disposition of doxorubicin in rats.
Zhou Q; Chowbay B
Eur J Drug Metab Pharmacokinet; 2002; 27(3):185-92. PubMed ID: 12365200
[TBL] [Abstract][Full Text] [Related]
9. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.
Chin DL; Lum BL; Sikic BI
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):259-69. PubMed ID: 12361740
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.
Andersen A; Warren DJ; Slørdal L
Cancer Chemother Pharmacol; 1994; 34(3):197-202. PubMed ID: 8004751
[TBL] [Abstract][Full Text] [Related]
11. HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.
Beijnen JH; Meenhorst PL; van Gijn R; Fromme M; Rosing H; Underberg WJ
J Pharm Biomed Anal; 1991; 9(10-12):995-1002. PubMed ID: 1822225
[TBL] [Abstract][Full Text] [Related]
12. A sensitive high-performance liquid chromatographic method for the determination of 6-mercaptopurine in plasma using precolumn derivatization and fluorescence detection.
Warren DJ; Slørdal L
Ther Drug Monit; 1993 Feb; 15(1):25-30. PubMed ID: 8451776
[TBL] [Abstract][Full Text] [Related]
13. Determination of doxorubicin and its metabolites in rat serum and bile by LC: application to preclinical pharmacokinetic studies.
Zhou Q; Chowbay B
J Pharm Biomed Anal; 2002 Nov; 30(4):1063-74. PubMed ID: 12408897
[TBL] [Abstract][Full Text] [Related]
14. A sensitive and simple high-performance liquid chromatographic method for the determination of mitoxantrone in plasma.
Slørdal L; Andersen A; Warren DJ
Ther Drug Monit; 1993 Aug; 15(4):328-33. PubMed ID: 8236369
[TBL] [Abstract][Full Text] [Related]
15. A sensitive and simple high-performance liquid chromatographic method for the determination of doxorubicin and its metabolites in plasma.
Andersen A; Warren DJ; Slørdal L
Ther Drug Monit; 1993 Oct; 15(5):455-61. PubMed ID: 8249054
[TBL] [Abstract][Full Text] [Related]
16. Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Doxorubicin and its Metabolites Doxorubicinol, Doxorubicinone, Doxorubicinolone, and 7-Deoxydoxorubicinone in Mouse Plasma.
Choi WG; Kim DK; Shin Y; Park R; Cho YY; Lee JY; Kang HC; Lee HS
Molecules; 2020 Mar; 25(5):. PubMed ID: 32164308
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
